Universal x-ray screening of tuberculosis has limited value, carries potentially adverse effects for patients, and creates an unnecessary cost burden, according to a study presented Monday at the 2009 RSNA meeting.
Universal x-ray screening of tuberculosis has limited value, carries potentially adverse effects for patients, and creates an unnecessary cost burden, according to a study presented Monday at the 2009 RSNA meeting.
Since most cases arise from reactivation of a dormant foci of infection, the treatment of latent tuberculosis represents a major component of the national strategy for wiping out the disease from the U.S. Thus, screening with the purified protein derivative (PPD) exam, also known as the Mantoux test, remains popular across the country.
For their parts, the American Thoracic Society and the Centers for Disease Control recommend that all PPD-positive individuals undergo routine chest radiography to exclude clinically active TB or to detect evidence of disease that would further increase risk of reactivation. However, findings from several small studies performed recently in the U.S. and abroad have found little radiographic evidence of active TB in this population, said lead investigator Dr. Ronald Eisenberg, an associate professor of radiology at Harvard.
Beginning in 2003, Eisenberg and coauthor Dr. Nira Pollock reviewed screening chest x-rays from PPD-positive individuals before their employment as healthcare workers. Using standard criteria, the investigators looked for signs of active or latent prior tuberculosis in the otherwise healthy subjects who were identified over the course of five years.
Even though abnormalities came up in the chest radiographs of 159, or about 6.1%, of 2586 PPD-positive individuals, researchers found no signs of active tuberculosis.
"The results of chest radiography did not clarify whom we should prioritize for prophylactic anti-TB treatment," Eisenberg said. "Of course, radiographic findings must be interpreted in context with the individual's exposure and medical history, so making the overall assessment of realistic reactivation risk is a significant challenge."
Nearly 60% of cases showed evidence of calcified granulomas, inflamed lymph nodes, or both. The rest came up with signs of pleural thickening (15.7%), fibrous scarring (10%), and noncalcified nodules (19.5%).
Such extremely low yield led researchers to conclude that the published guidelines for the interpretation of x-ray screening findings are inconsistent and out of date.
"Given the cumulative adverse effect and cost of chest radiography in current tuberculosis screening programs, these guidelines should be urgently revisited," Eisenberg said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.